Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 326
Filtrar
2.
Eur J Vasc Endovasc Surg ; 68(2): 210-217, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38754725

RESUMEN

OBJECTIVE: The International Commission on Radiological Protection has highlighted the large number of medical specialties that use fluoroscopy outside diagnostic imaging departments without radiation protection programmes for patients and staff. Vascular surgery is one of these specialties. Thoracic endovascular aortic repair (TEVAR) is a complicated procedure requiring radiation protection guidance and optimisation. The recent EU Basic Safety Standards Directive requires the use and periodic updating of diagnostic reference levels (DRLs) for interventional procedures. The aim of this study was to determine doses for patients undergoing TEVAR with mobile Xray systems and hybrid rooms (fixed Xray systems) to obtain national DRLs and to suggest optimisation actions. METHODS: This was a retrospective cross sectional study. The Spanish Chapter of Endovascular Surgery conducted a national survey in 11 autonomous communities representing around 77.6% of the Spanish population (47.33 million inhabitants). A total of 266 TEVAR procedures from 17 Spanish centres were analysed, of which 53.0% were performed in hybrid operating rooms. National DRLs were obtained and defined as the third quartile of the median values from the different participating centres. RESULTS: The proposed national DRLs are: for kerma area product (KAP), 113.81 Gy·cm2 for mobile Xray systems and 282.59 Gy·cm2 for hybrid rooms; and for cumulative air kerma (CAK) at the patient entry reference point, 228.38 mGy for mobile systems and 910.64 mGy for hybrid rooms. CONCLUSION: Based on the requirement to know radiation doses for standard endovascular procedures, this study of TEVARs demonstrated that there is an increased factor of 2.48 in DRLs for KAP when the procedure is performed in a hybrid room compared with mobile C-arm systems, and an increased factor of 3.98 in DRLs for CAK when the procedure is performed with hybrid equipment. These results will help to optimise strategies to reduce radiation doses during TEVAR procedures.


Asunto(s)
Aorta Torácica , Reparación Endovascular de Aneurismas , Dosis de Radiación , Femenino , Humanos , Masculino , Aorta Torácica/cirugía , Aorta Torácica/diagnóstico por imagen , Estudios Transversales , Reparación Endovascular de Aneurismas/efectos adversos , Reparación Endovascular de Aneurismas/normas , Fluoroscopía/normas , Exposición a la Radiación/prevención & control , Exposición a la Radiación/efectos adversos , Protección Radiológica/normas , Radiografía Intervencional/efectos adversos , Radiografía Intervencional/normas , Valores de Referencia , Estudios Retrospectivos , España
4.
J Vasc Interv Radiol ; 35(8): 1097-1103, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38685470

RESUMEN

Genicular artery embolization (GAE) is an emerging, minimally invasive therapy to address the global burden of knee osteoarthritis (OA) and the unmet needs for medically refractory disease. Although total knee arthroplasty has been a standard intervention for severe cases, GAE is developing into a promising alternative, particularly for patients ineligible for or unwilling to undergo surgery. GAE targets the inflammatory cascade underlying OA pathophysiology by arresting neoangiogenesis and preventing pathological neoinnervation, offering potential pain relief. Although early studies have established safety and short-term effectiveness, ensuing studies are needed to validate long-term safety, durability, and comparative effectiveness and to optimize patient selection, embolic agent selection, and administration techniques. Standardized reporting guidelines are therefore essential to enhance transparency and reproducibility across clinical trials, facilitating data aggregation and comparison. This Society of Interventional Radiology (SIR)-endorsed reporting standards consensus document provides a framework to harmonize future research efforts and to improve the interpretation of outcomes.


Asunto(s)
Consenso , Embolización Terapéutica , Osteoartritis de la Rodilla , Humanos , Embolización Terapéutica/normas , Embolización Terapéutica/efectos adversos , Resultado del Tratamiento , Osteoartritis de la Rodilla/terapia , Osteoartritis de la Rodilla/diagnóstico por imagen , Proyectos de Investigación/normas , Radiografía Intervencional/normas
6.
Cardiovasc Revasc Med ; 64: 70-75, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38538447

RESUMEN

OBJECTIVES: This study evaluated the efficacy of a novel comprehensive shield designed to minimize radiation exposure (RE) to Physicians performing coronary and structural heart procedures. BACKGROUND: The Protego™ radiation shielding system (Image Diagnostics Inc., Fitchburg, Ma) is designed to provide comprehensive protection from RE and has been State certified sufficient to allow operators to perform procedures without orthopedically burdensome lead aprons. METHODS: This single center two-group cohort study assessed the efficacy of this shield in a large number of cardiac procedures (coronary and structural), comparing operator RE compared to standard protection methods (personal lead apparel and "drop down" shield). RESULTS: The Protego™ system reduced operator RE by 99 % compared to Standard Protection. RE was significantly lower at both "Head" level by thyroid median dose 0.0 (0.0, 0,0) vs 5.7 (2.9, 8.2) µSv (p < 0.001), as well as waist dose 0.0 (0.0, 0.0) vs 10.0 (5.0, 16.6) µSv (p < 0.001). "Zero" Total RE was documented by Raysafe™ in 64 % (n = 32) of TAVR cases and 73.2 % (n = 183) of the coronary cases utilizing Protego™. In contrast, standard protection did not achieve "Zero" exposure in a single case. These dramatic differences in RE were achieved despite higher fluoroscopy times in the Protego™ arm (11.9 ± 8.6 vs 14.3 ± 12.5 min, p = 0.015). Per case procedural exposure measured by Dose Area Product was higher in the Protego™ group compared to standard protection (115.4 ± 139.2 vs 74.9 ± 69.3, p < 0.001). CONCLUSION: The Protego™ shield provides total body RE protection for operators performing both coronary and structural heart procedures. This shield allows procedural performance without the need for personal lead aprons and has potential to reduce catheterization laboratory occupational health hazards.


Asunto(s)
Exposición Profesional , Salud Laboral , Dosis de Radiación , Exposición a la Radiación , Protección Radiológica , Radiografía Intervencional , Humanos , Exposición Profesional/prevención & control , Exposición Profesional/efectos adversos , Exposición a la Radiación/prevención & control , Exposición a la Radiación/efectos adversos , Protección Radiológica/instrumentación , Radiografía Intervencional/efectos adversos , Radiografía Intervencional/normas , Factores de Riesgo , Medición de Riesgo , Traumatismos por Radiación/prevención & control , Traumatismos por Radiación/etiología , Diseño de Equipo , Cateterismo Cardíaco/efectos adversos , Cateterismo Cardíaco/instrumentación , Masculino , Monitoreo de Radiación , Femenino
7.
J Vasc Interv Radiol ; 32(5): 677-682, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33933250

RESUMEN

In the merit-based incentive payment system (MIPS), quality measures are considered topped out if national median performance rates are ≥95%. Quality measures worth 10 points can be capped at 7 points if topped out for ≥2 years. This report compares the availability of diagnostic radiology (DR)-related and interventional radiology (IR)-related measures worth 10 points. A total of 196 MIPS clinical quality measures were reviewed on the Center for Medicare and Medicaid Services MIPS website. There are significantly more IR-related measures worth 10 points than DR measures (2/9 DR measures vs 9/12 IR measures; P = .03), demonstrating that clinical IR services can help mixed IR/DR groups maximize their Center for Medicare and Medicaid Services payment adjustment.


Asunto(s)
Benchmarking/economía , Diagnóstico por Imagen/economía , Costos de la Atención en Salud , Indicadores de Calidad de la Atención de Salud/economía , Radiografía Intervencional/economía , Radiología Intervencionista/economía , Benchmarking/normas , Centers for Medicare and Medicaid Services, U.S./economía , Diagnóstico por Imagen/normas , Costos de la Atención en Salud/normas , Humanos , Planes de Incentivos para los Médicos/economía , Indicadores de Calidad de la Atención de Salud/normas , Radiografía Intervencional/normas , Radiología Intervencionista/normas , Reembolso de Incentivo/economía , Estados Unidos
14.
J Cardiovasc Comput Tomogr ; 15(1): 2-15, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33032977

RESUMEN

Cardiovascular computed tomography (CCT) is a well-validated non-invasive imaging tool with an ever-expanding array of applications beyond the assessment of coronary artery disease. These include the evaluation of structural heart diseases, congenital heart diseases, peri-procedural electrophysiology applications, and the functional evaluation of ischemia. This breadth requires a robust and diverse training curriculum to ensure graduates of CCT training programs meet minimum competency standards for independent CCT interpretation. This statement from the Society of Cardiovascular Computed Tomography aims to supplement existing societal training guidelines by providing a curriculum and competency framework to inform the development of a comprehensive, integrated training experience for cardiology and radiology trainees in CCT.


Asunto(s)
Cardiólogos/educación , Cardiología/educación , Educación de Postgrado en Medicina , Radiografía Intervencional , Radiólogos/educación , Radiología Intervencionista/educación , Tomografía Computarizada por Rayos X , Cardiólogos/normas , Cardiología/normas , Competencia Clínica , Consenso , Curriculum , Educación de Postgrado en Medicina/normas , Humanos , Radiografía Intervencional/normas , Radiólogos/normas , Radiología Intervencionista/normas , Especialización , Tomografía Computarizada por Rayos X/normas
15.
Tech Vasc Interv Radiol ; 23(3): 100696, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33308526

RESUMEN

There are active debates surrounding patient evaluation and procedural techniques of prostate artery embolization. This review evaluates the available evidence on the value of urodynamics, the effect of prostate gland size, the benefits of pre- and intraprocedural cross-sectional imaging, the utility of a balloon-occlusion microcatheter, the differences among embolic particle sizes and types, and the merits of radial versus femoral arterial access.


Asunto(s)
Embolización Terapéutica/normas , Síntomas del Sistema Urinario Inferior/terapia , Próstata/irrigación sanguínea , Hiperplasia Prostática/terapia , Radiografía Intervencional/normas , Toma de Decisiones Clínicas , Embolización Terapéutica/efectos adversos , Humanos , Síntomas del Sistema Urinario Inferior/diagnóstico por imagen , Síntomas del Sistema Urinario Inferior/fisiopatología , Masculino , Selección de Paciente , Hiperplasia Prostática/diagnóstico por imagen , Hiperplasia Prostática/fisiopatología , Calidad de Vida , Radiografía Intervencional/efectos adversos , Recuperación de la Función , Factores de Riesgo , Resultado del Tratamiento , Urodinámica
16.
Tech Vasc Interv Radiol ; 23(3): 100695, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33308532

RESUMEN

Medically refractory benign prostatic hyperplasia induced lower urinary tract symptoms is an extremely prevalent issue in older men. The current gold standard therapy transurethral resection of the prostate does produce urologic improvements but is also associated with higher than desired morbidity. This has led to the need to develop new minimally invasive means to treat this disease; prostate artery embolization (PAE) has emerged as one minimally invasive treatment option for these patients. The body of evidence which supports the use of PAE has grown quickly and substantially over the last decade. The goal of this review is to introduce and summarize the published urologic outcomes for PAE when utilized to treat benign prostatic hyperplasia induced lower urinary tract symptoms as well as document the established complication profile. Finally, the paper reviews current societal recommendations as they relate to PAE.


Asunto(s)
Embolización Terapéutica/normas , Medicina Basada en la Evidencia/normas , Síntomas del Sistema Urinario Inferior/terapia , Guías de Práctica Clínica como Asunto/normas , Próstata/irrigación sanguínea , Hiperplasia Prostática/terapia , Radiografía Intervencional/normas , Embolización Terapéutica/efectos adversos , Humanos , Síntomas del Sistema Urinario Inferior/diagnóstico por imagen , Síntomas del Sistema Urinario Inferior/fisiopatología , Masculino , Hiperplasia Prostática/diagnóstico por imagen , Hiperplasia Prostática/fisiopatología , Calidad de Vida , Radiografía Intervencional/efectos adversos , Recuperación de la Función , Resultado del Tratamiento , Urodinámica
18.
Br J Radiol ; 93(1116): 20200814, 2020 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-32822543

RESUMEN

Notwithstanding that 100 mSv is not a threshold for radiation effects, cumulative effective dose (CED) for patients of ≥100 mSv derived from recurrent imaging procedures with ionising radiation has been recently the topic of several publications. The International Commission on Radiological Protection has alerted on the problems to use effective dose for risk estimation in individual patients but has accepted to use this quantity for comparison the relative radiation risks between different imaging modalities. A new International Commission on Radiological Protection document on the use of effective dose (including medicine), is in preparation. Recently published data on the number of patients with CED ≥100 mSv ranged from 0.6 to 3.4% in CT and around 4% in interventional radiology. The challenges to manage the existing situation are summarised. The main aspects identified are: 1) New technology with dose reduction techniques. 2) Refinements in the application of the justification and optimisation for these groups of patients. 3) Patient dose management systems with alerts on the cumulative high doses. 4) Education on the proper use of cumulative effective dose for referrers and practitioners including information for patients. 5) Future research programmes in radiation biology and epidemiology may profit the patient dose data from the groups with high cumulative dose values.


Asunto(s)
Dosis de Radiación , Protección Radiológica , Radiografía Intervencional/normas , Tomografía Computarizada por Rayos X/normas , Humanos , Protección Radiológica/normas
19.
Eur Radiol ; 30(10): 5690-5701, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32361774

RESUMEN

OBJECTIVES: To establish national reference levels (RLs) in interventional procedures under CT guidance as required by the 2013/59/Euratom European Directive. METHODS: Seventeen categories of interventional procedures in thoracic, abdominopelvic, and osteoarticular specialties (percutaneous infiltration, vertebroplasty, biopsy, drainage, tumor destruction) were analyzed. Total dose length product (DLP), number of helical acquisitions (NH), and total DLP for helical, sequential, or fluoroscopic acquisitions were recorded for 10 to 20 patients per procedure at each center. RLs were calculated as the 3rd quartiles of the distributions and target values for optimization process (TVOs) as the median. RLs and TVOs were compared with previously published studies. RESULTS: Results on 5001 procedures from 49 centers confirmed the great variability in patient dose for the same category of procedures. RLs were proposed for the DLPs and NHs in the seventeen categories. RLs in terms of DLP and NH were 375 mGy.cm and 2 NH for spinal or peri-spinal infiltration, 1630 mGy.cm and 3 NH for vertebroplasty, 845 mGy.cm and 4 NH for biopsy, 1950 mGy.cm and 8 NH for destruction of tumors, and 1090 mGy.cm and 5 NH for drainage. DLP and NH increased with the complexity of procedures. CONCLUSIONS: This study was the first nationwide multicentric survey to propose RLs for interventional procedures under CT guidance. Heterogeneity of practice in centers were found with different levels of patient doses for the same procedure. The proposed RLs will allow imaging departments to benchmark their practice with others and optimize their protocols. KEY POINTS: • National reference levels are proposed for 17 categories of interventional procedures under CT guidance. • Reference levels are useful for benchmarking practices and optimizing protocols. • Reference levels are proposed for dose length product and the number of helical acquisitions.


Asunto(s)
Dosis de Radiación , Radiografía Intervencional/normas , Valores de Referencia , Tomografía Computarizada por Rayos X/normas , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Femenino , Fluoroscopía/métodos , Francia , Humanos , Masculino , Persona de Mediana Edad , Radiografía Intervencional/métodos , Reproducibilidad de los Resultados , Estudios Retrospectivos , Columna Vertebral , Encuestas y Cuestionarios , Tomografía Computarizada por Rayos X/métodos , Vertebroplastia , Adulto Joven
20.
AJR Am J Roentgenol ; 215(6): 1499-1503, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32442029

RESUMEN

OBJECTIVE. The purpose of this article is to present strategies and guidelines that can be implemented in the performance of cross-sectional interventional procedures during the coronavirus disease (COVID-19) pandemic. CONCLUSION. Radiologists who perform cross-sectional interventional procedures can take several steps to minimize the risks to patients and radiology personnel, including screening referred patients to decide which procedures can be postponed, using appropriate personal protective equipment (PPE), minimizing the number of people involved in procedures, preserving PPE when possible, and applying proper room and equipment cleaning measures.


Asunto(s)
COVID-19/prevención & control , Control de Infecciones/normas , Radiografía Intervencional/normas , Servicio de Radiología en Hospital/normas , COVID-19/epidemiología , Guías como Asunto , Humanos , Pandemias , Selección de Paciente , Equipo de Protección Personal , SARS-CoV-2 , Estados Unidos/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...